Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain - Concepedia

Concepedia

Publication | Open Access

Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain

DOI Full Paper Access

19

Citations

39

References

2017

Year

Pedro Mezquita‐Raya, Antonio Ramírez de Arellano, Nana Kragh, G. Vega-Hernández, Johannes Pöhlmann, William J. Valentine, Barnaby Hunt

Diabetes Therapy

References

	Year	Citations

Page 1